Nicholas W Alexos
CIK 1246224 · View on SEC EDGAR ↗
First SEC filing: Oct. 12, 2017 · Latest: Oct. 12, 2017
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2018 | XRAY | P | 50,000 | $44.71 | $2,235,500 | 50,000 Indirect | — | Acquired | -75.5% (price as of 2026-08-20) |
| Nov. 13, 2017 | XRAY | P | 50,000 | $65.85 | $3,292,500 | 50,000 Indirect | — | Acquired | -83.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 12, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (3) | — | — | 3 | Acquired |
| April 12, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (3) | — | — | 3 | Acquired |
| March 29, 2019 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (1,690) | — | — | 1,690 | Acquired |
| March 12, 2019 | XRAY | Stock Option (Right to Buy) | Common Stock (35,900) | $49.29 | March 12, 2022 | 35,900 | Acquired |
| March 6, 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (34,600) | $56.37 | March 6, 2021 | 34,600 | Acquired |
| Oct. 10, 2017 | XRAY | Stock Option (Right to Buy) | Common Stock (38,100) | $57.57 | Oct. 10, 2027 | 38,100 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $134,795 | — | — | — | $41,100 | — | — | $1,733,673 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.